Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) shares gapped down before the market opened on Tuesday following insider selling activity. The stock had previously closed at $432.74, but opened at $403.16. Astera Labs shares last traded at $383.8370, with a volume of 814,194 shares traded.
Specifically, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This represents a 9.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 37,535 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $447.39, for a total value of $16,792,783.65. Following the completion of the sale, the director owned 295,354 shares of the company’s stock, valued at $132,138,426.06. This represents a 11.28% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In other news, Director Manuel Alba sold 8,491 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the sale, the director owned 286,863 shares of the company’s stock, valued at approximately $131,492,261.94. This trade represents a 2.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on ALAB shares. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Bank of America lifted their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Morgan Stanley boosted their price target on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Susquehanna increased their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Finally, Royal Bank Of Canada raised their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average price target of $265.75.
Astera Labs Stock Performance
The firm has a market cap of $65.63 billion, a P/E ratio of 258.70, a P/E/G ratio of 4.66 and a beta of 3.66. The company has a 50-day moving average of $314.72 and a 200 day moving average of $205.99.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the firm earned $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.
Institutional Investors Weigh In On Astera Labs
Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Reflection Asset Management acquired a new stake in shares of Astera Labs during the 4th quarter worth about $25,000. Smartleaf Asset Management LLC boosted its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares in the last quarter. Hilltop National Bank boosted its position in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares in the last quarter. Aventura Private Wealth LLC bought a new stake in Astera Labs during the fourth quarter worth about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in Astera Labs during the fourth quarter worth about $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
- Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
